Genetic loss of SH2B3 in acute lymphoblastic leukemia

Blood

Volumn 122, Issue 14, 2013, Pages 2425-2432

  Perez Garcia, Arianne ^a   Ambesi Impiombato, Alberto ^a   Hadler, Michael ^a   Rigo, Isaura ^a   LeDuc, Charles A ^b   Kelly, Kara ^b   Jalas, Chaim ^c   Paietta, Elisabeth ^d   Racevskis, Janis ^d   Rowe, Jacob M ^e,f   Tallman, Martin S ^g   Paganin, Maddalena ^h   Basso, Giuseppe ^h   Tong, Wei ⁱ   Chung, Wendy K ^b   Ferrando, Adolfo A ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c Bonei Olam   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^f SHAARE ZEDEK MEDICAL CENTER   (Israel)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE; NOTCH1 RECEPTOR; STAT3 PROTEIN; LNK PROTEIN, HUMAN; PROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BONE MARROW BIOPSY; CASE REPORT; CELL PROLIFERATION; CHILD; CHRONIC HEPATITIS; CONTROLLED STUDY; DEVELOPMENTAL DELAY; FAMILY HISTORY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE; GENETIC PREDISPOSITION; GERMLINE MUTATION; GROWTH RETARDATION; HASHIMOTO DISEASE; HEPATOSPLENOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMOGENESIS; LIVER CIRRHOSIS; LOSS OF FUNCTION MUTATION; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SH2B ADAPTOR PROTEIN 3 GENE; SIBLING; SINGLE UMBILICAL ARTERY; SMALL FOR DATE INFANT; SOMATIC MUTATION; SPEECH DELAY; ANIMAL; AUTOIMMUNE DISEASE; C57BL MOUSE; DEVELOPMENTAL DISORDER; DNA MICROARRAY; GENETICS; GENOTYPE; INFANT; MOLECULAR GENETICS; MUTATION; NEWBORN; NUCLEOTIDE SEQUENCE; PEDIGREE; WESTERN BLOTTING;

ANIMALS; AUTOIMMUNE DISEASES; BASE SEQUENCE; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENOTYPE; GERM-LINE MUTATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEDIGREE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROTEINS; SIBLINGS;

EID: 84887805156     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2013-05-500850     Document Type: Article

References (53)

1. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer. 2006;6(3):193-203.
2. Treviño LR, Yang W, French D, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet. 2009;41(9): 1001-1005.
3. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet. 2009;41(9): 1006-1010.
4. Sherborne AL, Hosking FJ, Prasad RB, et al. Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk. Nat Genet. 2010;42(6):492-494.
5. Yang W, Treviño LR, Yang JJ, et al. ARID5B SNP rs10821936 is associated with risk of childhood acute lymphoblastic leukemia in blacks and contributes to racial differences in leukemia incidence. Leukemia. 2010;24(4):894-896.
6. Xu H, Yang W, Perez-Andreu V, et al. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations. J Natl Cancer Inst. 2013;105(10):733-742.
7. Nishimoto N, Imai Y, Ueda K, et al. T cell acute lymphoblastic leukemia arising from familial platelet disorder. Int J Hematol. 2010;92(1): 194-197.
8. Martínez-Glez V, Lapunzina P. Sotos syndrome is associated with leukemia/lymphoma. Am J Med Genet A. 2007;143A(11):1244-1245.
9. Ziino O, Rondelli R, Micalizzi C, Luciani M, Conter V, Aricò M. Acute lymphoblastic leukemia in children with associated genetic conditions other than Down's syndrome. The AIEOP experience. Haematologica. 2006;91(1):139-140.
10. Chao MM, Todd MA, Kontny U, et al. T-cell acute lymphoblastic leukemia in association with Börjeson-Forssman-Lehmann syndrome due to a mutation in PHF6. Pediatr Blood Cancer. 2010; 55(4):722-724.
11. O'Connell JR, Weeks DE. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet. 1998;63(1): 259-266.
12. Seelow D, Schuelke M, Hildebrandt F, Nurnberg P. Homozygosity Mapper-an interactive approach to homozygosity mapping. Nucleic Acids Res. 2009;37(Web Server issue):W593-599.
13. Ventura M, Gibaud A, Le Pendu J, et al. Use of a simple method for the Epstein-Barr virus transformation of lymphocytes from members of large families of Réunion Island. Hum Hered. 1988;38(1):36-43.
14. Gould J, Getz G, Monti S, Reich M, Mesirov JP. Comparative gene marker selection suite. Bioinformatics. 2006;22(15):1924-1925.
15. Novershtern N, Subramanian A, Lawton LN, et al. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell. 2011;144(2):296-309.
16. Rudd CE. Lnk adaptor: novel negative regulator of Bcell lymphopoiesis. SciSTKE. 2001;2001(85):pe1.
17. Velazquez L, Cheng AM, Fleming HE, et al. Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med. 2002;195(12):1599-1611.
18. Takaki S, Tezuka Y, Sauer K, et al. Impaired lymphopoiesis and altered B cell subpopulations in mice overexpressing Lnk adaptor protein. J Immunol. 2003;170(2):703-710.
19. Ema H, Sudo K, Seita J, et al. Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. Dev Cell. 2005;8(6):907-914.
20. Bersenev A, Wu C, Balcerek J, Tong W. Lnk controls mouse hematopoietic stem cell selfrenewal and quiescence through direct interactions with JAK2. J Clin Invest. 2008;118(8): 2832-2844.
21. Pear WS, Aster JC, Scott ML, et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med. 1996;183(5): 2283-2291.
22. Palomero T, Barnes KC, Real PJ, et al. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors. Leukemia. 2006;20(7):1279-1287.
23. Huang X, Li Y, Tanaka K, Moore KG, Hayashi JI. Cloning and characterization of Lnk, a signal transduction protein that links T-cell receptor activation signal to phospholipase C gamma 1, Grb2, and phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA. 1995;92(25):11618-11622.
24. Takaki S, Watts JD, Forbush KA, et al. Characterization of Lnk. An adaptor protein expressed in lymphocytes. J Biol Chem. 1997; 272(23):14562-14570.
25. Simon C, Dondi E, Chaix A, et al. Lnk adaptor protein down-regulates specific Kit-induced signaling pathways in primary mast cells. Blood. 2008;112(10):4039-4047.
26. Gueller S, Goodridge HS, Niebuhr B, et al. Adaptor protein Lnk inhibits c-Fms-mediated macrophage function. J Leukoc Biol. 2010;88(4): 699-706.
27. Gueller S, Hehn S, Nowak V, et al. Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling. Exp Hematol. 2011; 39(5):591-600.
28. Lin DC, Yin T, Koren-Michowitz M, et al. Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3. Blood. 2012;120(16):3310-3317.
29. Baran-Marszak F, Magdoud H, Desterke C, et al. Expression level and differential JAK2-V617Fbinding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms. Blood. 2010;116(26):5961-5971.
30. Takaki S, Morita H, Tezuka Y, Takatsu K. Enhanced hematopoiesis by hematopoietic progenitor cells lacking intracellular adaptor protein, Lnk. J Exp Med. 2002;195(2):151-160.
31. Seita J, Ema H, Ooehara J, et al. Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc Natl Acad Sci USA. 2007; 104(7):2349-2354.
32. Tong W, Zhang J, Lodish HF. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood. 2005;105(12):4604-4612.
33. Tong W, Lodish HF. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med. 2004;200(5): 569-580.
34. Takizawa H, Kubo-Akashi C, Nobuhisa I, et al. Enhanced engraftment of hematopoietic stem/progenitor cells by the transient inhibition of an adaptor protein, Lnk. Blood. 2006;107(7): 2968-2975.
35. Buza-Vidas N, Antonchuk J, Qian H, et al. Cytokines regulate postnatal hematopoietic stem cell expansion: opposing roles of thrombopoietin and LNK. Genes Dev. 2006;20(15):2018-2023.
36. Takaki S, Sauer K, Iritani BM, et al. Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins. Immunity. 2000;13(5): 599-609.
37. Shochat C, Tal N, Bandapalli OR, et al. Gain-offunction mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias. J Exp Med. 2011;208(5):901-908.
38. Mullighan CG, Collins-Underwood JR, Phillips LA, et al. Rearrangement of CRLF2 in B-progenitorand Down syndrome-associated acute lymphoblastic leukemia. Nat Genet. 2009;41(11): 1243-1246.
39. Russell LJ, Capasso M, Vater I, et al. Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia. Blood. 2009;114(13):2688-2698.
40. Harvey RC, Mullighan CG, Chen IM, et al. Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia. Blood. 2010;115(26):5312-5321.
41. Zenatti PP, Ribeiro D, Li W, et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia. Nat Genet. 2011; 43(10):932-939.
42. Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7(4):387-397.
43. Gery S, Cao Q, Gueller S, Xing H, Tefferi A, Koeffler HP. Lnk inhibits myeloproliferative disorder-associated JAK2 mutant, JAK2V617F. J Leukoc Biol. 2009;85(6):957-965.
44. Bersenev A, Wu C, Balcerek J, et al. Lnk constrains myeloproliferative diseases in mice. J Clin Invest. 2010;120(6):2058-2069.
45. Oh ST, Simonds EF, Jones C, et al. Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood. 2010; 116(6):988-992.
46. Lasho TL, Pardanani A, Tefferi A. LNK mutations in JAK2 mutation-negative erythrocytosis. N Engl J Med. 2010;363(12):1189-1190.
47. Hunt KA, Zhernakova A, Turner G, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet. 2008; 40(4):395-402.
48. Lavrikova EY, Nikitin AG, Kuraeva TL, et al. The carriage of the type 1 diabetes-associated R262W variant of human LNK correlates with increased proliferation of peripheral blood monocytes in diabetic patients. Pediatr Diabetes. 2011;12(2): 127-132.
49. Gudbjartsson DF, Bjornsdottir US, Halapi E, et al. Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet. 2009;41(3):342-347.
50. Alcina A, Vandenbroeck K, Otaegui D, et al. The autoimmune disease-associated KIF5A, CD226 and SH2B3 gene variants confer susceptibility for multiple sclerosis. Genes Immun. 2010;11(5): 439-445.
51. Roberts KG, Morin RD, Zhang J, et al. Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia. Cancer Cell. 2012;22(2):153-166.
52. Zhang J, Ding L, Holmfeldt L, et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature. 2012;481(7380):157-163.
53. Maude SL, Tasian SK, Vincent T, et al. Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemia. Blood. 2012;120(17):3510-3518.